Earnings History Data for NeoGenomics, Inc. (NEO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
20-02-2024	AH		NEO	NeoGenomics, Inc.	1,900	-0.02	-0.07	-0.10	NeoGenomics Non-GAAP EPS of $0.03 beats by $0.06, revenue of $155.55M beats by $3.02M [2/20/2024 4:28 PM]	16.43	1.73 (11.77%)	16.40	1.70 (11.56%)	11.03 - 21.22	3,591,447	1,020,000	96,602
NeoGenomics Non-GAAP EPS of $0.03 beats by $0.06, revenue of $155.55M beats by $3.02M [2/20/2024 4:28 PM] NeoGenomics shares jump after revenue forecast tops Street expectations [2/21/2024 10:06 AM] Biggest stock movers today: Palo Alto Networks, Teladoc Health, and more [2/21/2024 10:14 AM]
06-11-2023	AH		NEO	NeoGenomics, Inc.	1,840	-0.06	-0.11	-0.17	NeoGenomics Non-GAAP EPS of $0.00 beats by $0.08, revenue of $152M beats by $10M [11/6/2023 4:46 PM]	16.75	2.10 (14.33%)	15.31	0.66 (4.51%)	7.01 - 20.54	2,559,692	940,000	4,672
NeoGenomics Non-GAAP EPS of $0.00 beats by $0.08, revenue of $152M beats by $10M [11/6/2023 4:46 PM]
08-08-2023	PM		NEO	NeoGenomics, Inc.	2,030	-0.09	-0.15	-0.19	NeoGenomics Non-GAAP EPS of -$0.05 beats by $0.06, revenue of $146.92M beats by $9.49M [8/8/2023 7:07 AM]	15.32	-0.48 (-3.01%)	15.80	0.0 (0.00%)	6.00 - 20.54	1,622,021	720,000	2,674
NeoGenomics Q2 2023 Earnings Preview [8/7/2023 12:45 PM] NeoGenomics Non-GAAP EPS of -$0.05 beats by $0.06, revenue of $146.92M beats by $9.49M [8/8/2023 7:07 AM]
08-05-2023	AH	After the close (May 8)	NEO	NeoGenomics, Inc.	1,840	-0.13	-0.16	-0.30	NeoGenomics Non-GAAP EPS of -$0.09 beats by $0.06, revenue of $137.2M beats by $10.81M [5/8/2023 4:26 PM]	18.25	2.85 (18.47%)	17.78	2.38 (15.45%)	6.00 - 19.51	3,122,355	970,000	24,069
NeoGenomics Non-GAAP EPS of -$0.09 beats by $0.06, revenue of $137.2M beats by $10.81M [5/8/2023 4:26 PM] NeoGenomics up 21% as BTIG upgrades to Buy after strong Q1 beat [5/9/2023 11:00 AM]
23-02-2023	PM	0:00 AM ET (Feb 23)	NEO	NeoGenomics, Inc.	1,760	-0.10	-0.19	-0.14	NeoGenomics beats Q4 top and bottom line estimates; initiates FY23 outlook [2/23/2023 7:09 AM]	16.61	3.26 (24.42%)	14.60	1.25 (9.36%)	6.00 - 21.94	5,072,326	930,000	9,735
NeoGenomics Q4 2022 Earnings Preview [2/22/2023 12:51 PM] NeoGenomics beats Q4 top and bottom line estimates; initiates FY23 outlook [2/23/2023 7:09 AM] NeoGenomics surges ~20% as Q4 revenue grows, net loss narrows; FY23 outlook above estimates [2/23/2023 11:12 AM]
08-11-2022	PM	0:00 AM ET (Nov 8)	NEO	NeoGenomics, Inc.	905.73	-0.17	-0.23	-0.13	NeoGenomics Non-GAAP EPS of -$0.14 beats by $0.07, revenue of $128.78M beats by $7.24M [11/8/2022 7:09 AM]	8.90	1.80 (25.35%)	7.10	0.0 (0.00%)	6.00 - 44.26	2,896,760	1,600,000	11,709
NeoGenomics Non-GAAP EPS of -$0.14 beats by $0.07, revenue of $128.78M beats by $7.24M [11/8/2022 7:09 AM] NeoGenomics surges 28% on Q3 beat as clinical services revenue grows [11/8/2022 11:57 AM] NeoGenomics Reports Third Quarter 2022 Results [Nov-08-22 07:00AM] NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors [Nov-07-22 04:35PM]
09-08-2022	PM	7:30 AM ET (Aug 9)	NEO	NeoGenomics, Inc.	1,180	-0.19	-0.28	-0.04	NeoGenomics Non-GAAP EPS of -$0.16 beats by $0.07, revenue of $125.07M beats by $1.81M [8/9/2022 7:06 AM]	11.67	1.44 (14.08%)	10.70	0.47 (4.59%)	6.85 - 54.74	4,695,099	1,850,000	4,209
NeoGenomics Q2 2022 Earnings Preview [8/8/2022 2:14 PM] NeoGenomics Non-GAAP EPS of -$0.16 beats by $0.07, revenue of $125.07M beats by $1.81M [8/9/2022 7:06 AM] NeoGenomics rises ~14% on strong Q2 result [8/9/2022 11:52 AM]
27-04-2022	PM	0:00 AM ET (Apr 27)	NEO	NeoGenomics, Inc.	1,400	-0.30	-0.28	-0.06	NeoGenomics Non-GAAP EPS of -$0.20 beats by $0.04, revenue of $117.17M beats by $0.73M [4/27/2022 7:08 AM]	10.43	-0.42 (-3.87%)	11.30	0.45 (4.15%)	10.27 - 54.74	1,613,304	1,870,000	3,950
NeoGenomics Q1 2022 Earnings Preview [4/26/2022 2:06 PM] NeoGenomics Non-GAAP EPS of -$0.20 beats by $0.04, revenue of $117.17M beats by $0.73M [4/27/2022 7:08 AM] NeoGenomics Reports Revenue of $117 Million in the First Quarter [Apr-27-22 07:00AM] NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates [Apr-27-22 08:45AM]
23-02-2022	PM	0:00 AM ET (Feb 23)	NEO	NeoGenomics, Inc.	2,400	-0.14	-0.17	0.12	NeoGenomics Non-GAAP EPS of -$0.14 beats by $0.01, revenue of $125.73M in-line [2/23/2022 7:04 AM]	18.57	-0.15 (-0.80%)	18.72	0.0 (0.00%)	18.36 - 55.97	1,159,078	890,000	44,850
NeoGenomics Q4 2021 Earnings Preview [2/22/2022 11:23 AM] NeoGenomics Non-GAAP EPS of -$0.14 beats by $0.01, revenue of $125.73M in-line [2/23/2022 7:04 AM] NeoGenomics Reports Full Year Revenue of $484 Million and $126 Million for the Fourth Quarter of 2021 [Feb-23-22 07:00AM] NeoGenomics (NEO) Reports Q4 Loss, Tops Revenue Estimates [Feb-23-22 08:45AM]
04-11-2021	PM	9:45 AM ET (Nov 4)	NEO	NeoGenomics, Inc.	5,790	-0.13	-0.12	0.04	NeoGenomics EPS beats by $0.01, misses on revenue [11/4/2021 7:14 AM]	38.35	-8.18 (-17.58%)	38.35	0.0 (0.00%)	36.00 - 61.57	3,679,389	510,000	7,147
NeoGenomics Q3 2021 Earnings Preview [11/3/2021 1:38 PM] NeoGenomics EPS beats by $0.01, misses on revenue [11/4/2021 7:14 AM] NeoGenomics falls after earnings miss as full year outlook disappoints [11/4/2021 11:18 AM] NeoGenomics Reports Revenue of $121 Million in the Third Quarter [Nov-04-21 07:02AM] NeoGenomics Announces Leadership Team Transition [Nov-04-21 07:00AM] NeoGenomics (NEO) Reports Q3 Loss, Lags Revenue Estimates [Nov-04-21 10:55AM]
06-08-2021	PM	8:25 AM ET (Aug 6)	NEO	NeoGenomics, Inc.	5,650	-0.04	-0.08	-0.05	NeoGenomics EPS beats by $0.05, beats on revenue [8/6/2021 7:08 AM]	46.71	-1.00 (-2.10%)	47.71	0.0 (0.00%)	34.18 - 61.57	495,843	530,000	6,653
NeoGenomics EPS beats by $0.05, beats on revenue [8/6/2021 7:08 AM] NeoGenomics Reports 40% Revenue Growth to $122 Million in the Second Quarter [Aug-06-21 07:00AM] NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates [Aug-06-21 10:55AM] NeoGenomics, inc (NEO) Q2 2021 Earnings Call Transcript [Aug-06-21 05:30PM]
05-05-2021	PM	0:00 AM ET (May 5)	NEO	NeoGenomics, Inc.	5,760	-0.06	-0.01	-0.04	NeoGenomics EPS misses by $0.05, beats on revenue [5/5/2021 7:05 AM]	41.95	-5.62 (-11.81%)	41.95	0.0 (0.00%)	25.19 - 61.57	1,833,029	610,000	459
NeoGenomics Q1 2021 Earnings Preview [5/4/2021 12:57 PM] NeoGenomics to acquire liquid biopsy firm Inivata [5/5/2021 12:08 AM] NeoGenomics EPS misses by $0.05, beats on revenue [5/5/2021 7:05 AM] NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform [May-05-21 12:00AM] NeoGenomics, Inc. to Host Earnings Call [May-05-21 06:45AM] NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter [May-05-21 07:00AM] NeoGenomics Snaps Up Inivata [May-05-21 07:34AM] NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates [May-05-21 09:35AM] NeoGenomics Exercises Option To Acquire Remaining Stake In Inivata For $390M [May-05-21 08:38AM] Neogenomics Inc (NEO) Q1 2021 Earnings Call Transcript [May-05-21 06:01PM]
24-02-2021	PM	0:00 AM ET (Feb 24)	NEO	NeoGenomics, Inc.	6,160	0.12	0.04	0.08	NeoGenomics EPS beats by $0.08, beats on revenue [2/24/2021 7:11 AM]	54.49	1.50 (2.83%)	53.00	0.01 (0.02%)	20.47 - 61.57	843,010	747,726	8,734
NeoGenomics EPS beats by $0.08, beats on revenue [2/24/2021 7:11 AM] NeoGenomics Q4 2020 Earnings Preview [2/23/2021 11:28 AM] NeoGenomics announces CEO succession [2/24/2021 7:26 AM] NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter [Feb-24-21 07:01AM] NeoGenomics Announces CEO Succession [Feb-24-21 07:00AM] NeoGenomics, Inc. to Host Earnings Call [Feb-24-21 06:30AM] Is NeoGenomics, Inc. (NASDAQ:NEO) Expensive For A Reason? A Look At Its Intrinsic Value [Feb-24-21 01:44AM]
27-10-2020	PM	0:00 AM ET (Oct 27)	NEO	NeoGenomics, Inc.	4,570	0.04	0.03	0.04	NeoGenomics EPS beats by $0.02, misses on revenue [10/27/2020 7:02 AM]	41.29	-0.66 (-1.57%)	41.26	-0.69 (-1.64%)	20.04 - 44.58	1,050,228	696,750	1,684

28-07-2020	PM	8:25 AM ET (Jul 28)	NEO	NeoGenomics, Inc.	4,040	-0.05	-0.11	0.05	NeoGenomics EPS beats by $0.06, beats on revenue [7/28/2020 7:05 AM]	36.07	-0.75 (-2.04%)	0.0	0.0 (0.00%)	18.52 - 38.24	553,194	657,208	0